Publications by authors named "A Farruggio"

Article Synopsis
  • - The study aimed to understand what factors affect the adequacy and positivity of the p16/Ki-67 assay among HPV-positive individuals in the NTCC2 study, using data from ThinPrep slide analyses reported by three different laboratories.
  • - A total of 3100 HPV-positive cases were analyzed, revealing that 9.7% of reports were inadequate and 28.3% were positive, with certain factors like age, cytology results, and mRNA presence impacting these rates.
  • - The findings indicate that the quality and interpretation of p16/Ki-67 results are influenced by multiple variables, emphasizing the complexity of cervical cancer screening processes.
View Article and Find Full Text PDF

Background: p16/Ki-67 dual staining is a candidate biomarker for triaging human papillomavirus (HPV)-positive women. Reproducibility is needed for adopting a test for screening. This study assessed interlaboratory reproducibility in HPV-positive women.

View Article and Find Full Text PDF

The standard of care for the first-line treatment of advanced gastrointestinal stromal tumor (GIST) is represented by imatinib, which is given daily at a standard dosage until tumor progression. Resistance to imatinib commonly occurs through the clonal selection of genetic mutations in the tumor DNA, and an increase in imatinib dosage was demonstrated to be efficacious to overcome imatinib resistance. Wild-type GISTs, which do not display KIT or platelet-derived growth factor receptor alpha (PDGFRA) mutations, are usually primarily insensitive to imatinib and tend to rapidly relapse in course of treatment.

View Article and Find Full Text PDF

When constructing transgenic cell lines via plasmid DNA integration, precise targeting to a desired genomic location is advantageous. It is also often advantageous to remove the bacterial backbone, since bacterial elements can lead to the epigenetic silencing of neighboring DNA. The least cumbersome method to remove the plasmid backbone is recombinase-mediated cassette exchange (RMCE).

View Article and Find Full Text PDF

The plasmid vectors that express the full-length human dystrophin coding sequence in human cells was developed. Dystrophin, the protein mutated in Duchenne muscular dystrophy, is extraordinarily large, providing challenges for cloning and plasmid production in Escherichia coli. The authors expressed dystrophin from the strong, widely expressed CAG promoter, along with co-transcribed luciferase and mCherry marker genes useful for tracking plasmid expression.

View Article and Find Full Text PDF